期刊文献+

铁调素对小鼠单核细胞RAW264.7向破骨细胞分化的影响 被引量:3

Effects of hepcidin treatment on differentiation of mouse RAW264.7 monocytes into osteoclasts
下载PDF
导出
摘要 目的探讨铁调素对小鼠单核细胞株RAW264.7向成熟破骨细胞分化的影响。方法将不同浓度铁调素加入含有核因子KB受体活化因子配体(RANKL)的RAW264.7细胞培养基,24h后用CCK-8法检测细胞的增生活性;4d后对细胞进行抗酒石酸酸性磷酸酶(TRAP)染色,光镜下观察;用RT—PCR法检测TRAP、组织蛋白酶K(CTK)、金属蛋白酶9(MMM-9)基因表达;用酶联免疫吸附法(ELISA)检测上清液中TRAP-5b含量;24h后用共聚焦显微镜(CLSM)测定细胞内铁离子浓度。结果铁调素在0~800nmol/L浓度围内可增加RAW264.7细胞TRAP染色阳性数目,上调TRAP、CTK和MMP-9基因表达,增加上清液TRAP-Sb含量(P〈0.05),同时增加RAW264.7细胞内铁离子浓度(P〈0.05)。结论铁调素可以促进RAW264.7细胞向破骨细胞分化,其作用机制可能与铁调素增加细胞内铁离子有关。 Objective To investigate the effects of hepcidin on differentiation of mouse RAW264.7 monocytes into osteoclasts. Methods RAW264. 7 cells were treated with different concentrations of bepcidin in the presence of receptor activator of NF-Kb ligand (RANKL). Cell viability, the number of tartrate-resistant acid phosphatase (TRAP) - positive cells, levels of TRAP, cathepsin K (CTK) , and matrix metalloproteinase 9 (MMP-9) mRNA, and levels of TRAP-Sb protein in the supernatant were examined. The intracellular iron ion was measured by a confocal laser scanning microscope. Results Hepcidin at 0-800 nmol/1 could significantly increase the number of TRAP-positive MNCs, and up- regulate gene expression of TRAP, CTK, and MMP-9, and increase the concentration of TRAP-5b in the supernatant, and increase concentrations of intracellular iron of RANKL-induced RAW264. 7 cells (P 〈 0. 05 ). Conclusion Hepcidin can significantly facilitate RANKL-induced differentiation of RAW264.7 into osteoclasts in vitro. The mechanism behind accelerated differentiation involves increased levels of intracellular iron.
出处 《中华骨质疏松和骨矿盐疾病杂志》 2013年第3期225-231,共7页 Chinese Journal Of Osteoporosis And Bone Mineral Research
基金 国家自然科学基金(81273090) 江苏省自然科学基金(BK2012608) 苏州市科技计划项目(510303) 江苏省普通高等学校研究生计划项目(CXLX11_0086)
关键词 铁调素 破骨细胞 细胞分化 骨代谢 hepcidin osteoclast differentiation bone metabolism
  • 相关文献

参考文献30

  • 1Pietrangelo A. Hepcidin in human iron disorders: therapeu- tic implications [J]. J Hepatol, 2011, 54:173 - 181.
  • 2Parrow NL, Gardenghi S, Rivella S. Prospects for a hepci- din mimic to treat beta-thalassemia and hemochromatosis [J]. Expert Rev Hematol, 2011, 4:233 -235.
  • 3Li GF, Pan YZ, Sirois P, et al. Iron homeostasis in osteo- porosis and its clinical implications [ J ]. Osteoporos Int, 2012, 23:2403 -2408.
  • 4Xi Huang. Treatment of osteoporosis in peri-and post-meno- pausal women with hepcidin. United States Patent Applica- tion Publication, Pub. No. : US 2010/0204122 A1.
  • 5Zhang P, Xu YJ, Zhao DY, et al. Increased intraeellular iron and mineralization of cultured hFOB 1. 19 cells fol- lowing hepcidin activation through ferroportin-1 [ J ]. Saudi Med J, 2010, 31 : 1303 - 1308.
  • 6Li GF, Xu YJ, He YF, et al. Effect of hepcidin on intra- cellular calcium in human osteoblasts [ J ]. Mol Cell Bio- chem, 2012, 366 : 169 - 174.
  • 7Xu Y, Li G, Du B, et al. Hepcidin increases intracellular Ca2+ Of osteoblast hFOB1. 19 through L-type Ca:+ chan- nels [J]. RegulPept, 2011, 172:58 -61.
  • 8徐又佳,马勇,钱忠明,郭霞,王爱东,王栋梁,冯一中,李峰,张鹏,王冰.骨质疏松模型体内铁调素(Hepcidin)基因表达的相关研究[J].中国骨质疏松杂志,2007,13(10):686-691. 被引量:17
  • 9Nemeth E, Rivera S, Gabayan V, et al. IL-6 mediates hy- poferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepeidin [ J ]. J Clin Invest, 2004, 113:1271 - 1276.
  • 10Andriopoulos B Jr, Corradini E, Xia Y, et al. BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism [J]. Nat Genet, 2009, 41:482-487.

二级参考文献20

  • 1吴波,徐冰,黄添友,王金锐.维A酸致大鼠骨质疏松模型与机理研究[J].药学学报,1996,31(4):241-245. 被引量:72
  • 2徐又佳,钱忠明,俞晨.铁调素(Hepcidin)在骨质矿化中的作用[J].中国骨质疏松杂志,2005,11(4):541-543. 被引量:16
  • 3钱忠明,王琴,徐又佳,柯亚.铁调素调节蛋白(HJV)——一个新的铁代谢调节蛋白[J].生物化学与生物物理进展,2006,33(3):226-230. 被引量:11
  • 4马勇,徐又佳,王爱东,俞晨,王冰,张鹏,张振东.大鼠骨质疏松模型中肝脏Hepcidin基因表达的初步研究[J].苏州大学学报(医学版),2006,26(3):367-369. 被引量:12
  • 5Margaret MH, Linda BH, Vanessa A, et al. Dietary Iron Is Associated with Bone Mineral Density in Healthy Postmenopausal Women. Nutr, 2003, 133:3598-3602.
  • 6Isomura H, Fujie K, Shibata K, et al. Bone metabolism and oxidative stress in postmenopausal rats with iron overload. Toxicology, 2004, 197:93-100.
  • 7Maurer J, Harris MM, Stanford VA, et al. Dietary iron positively influences bone mineral density in postmenopausal women on hormone replacement therapy. Journal of Nutrition, 2005, 135:863-869.
  • 8Malecki EA, Buhl KM, Beard JL, et al. Bone structural and mechanical properties are affected by hypotransferrinemia but not by iron deficiency in mice. Bone Miner Res, 2000, 15:1641.
  • 9Denis MM, Aaron P, Dianne J, et al. Bone Morphology, Strength and Density Are Compromised in Iron-Deficlent Rats and Exacerbated by Calcium Restriction. J Nutr, 2002, 132:3135-3141.
  • 10Fleming RE, Sly WS. Hepcidin: a putative iron-regulatory hormone relevant to hereditary hemochromatosis and the anemia of chronic disease. Proc Natl Acad Sci USA, 2001, 98:8160-8162.

共引文献16

同被引文献39

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部